Mosaic ImmunoEngineering (OTCMKTS:CPMV) Announces Earnings Results

Mosaic ImmunoEngineering (OTCMKTS:CPMV) released its earnings results on Tuesday. The company reported ($0.02) earnings per share for the quarter, Zacks reports.

Mosaic ImmunoEngineering Stock Performance

Shares of OTCMKTS CPMV remained flat at $0.63 during mid-day trading on Tuesday. The company had a trading volume of 6 shares, compared to its average volume of 1,068. The stock has a market cap of $4.54 million, a price-to-earnings ratio of -4.18 and a beta of 0.15. The stock’s fifty day moving average price is $0.85 and its 200 day moving average price is $0.88. Mosaic ImmunoEngineering has a 52-week low of $0.10 and a 52-week high of $1.13.

Mosaic ImmunoEngineering Company Profile

Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.